Még nem toboroz
An Exploratory Study of Single-Dose Neoadjuvant Nivolumab Without Surgical Delay in Patients With Resectable HCC
NCT07902258· 2. fázis· National Taiwan University Hospital· Forrás
Contact: Dr.Ying-Chun Shen
Még nem toboroz
Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors
NCT07693855· National Taiwan University Hospital· Forrás
Contact: Feng-Ming Hsu, M.D., Ph.D. (principal investigator)
Toboroz
ULTRA-high-risk Surveillance to Avoid Future Events: the ULTRA-SAFE Trial
NCT07378930· National Taiwan University Hospital· Forrás
Contact: Wei-Yuan Chang, MS
Toboroz
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás
Contact: Boehringer Ingelheim
Toboroz
3D Virtual Resection for Predicting Lung Function in VATS
NCT07436598· National Taiwan University Hospital· Forrás
Contact: Chih-Hsiang Chang, MD
Toboroz
Ameliorated Pap Tests and Cervical Cancer Screening Participation
NCT06968871· National Taiwan University Hospital· Forrás
Contact: Ching-Ming Chiu, MD
Toboroz
Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T
NCT07621692· 1. fázis· National Taiwan University Hospital· Forrás
Contact: Dr. Chuang
Még nem toboroz
Effect of Technology-Assisted Preoperative Home Exercise on Postoperative Handgrip Strength, Muscle Endurance, and Psychological Distress in Patients With Pulmonary Nodules Undergoing Video-Assisted Thoracoscopic Surgery
NCT07302217· National Taiwan University Hospital· Forrás
Contact: Li-Ping Chen
Toboroz
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
NCT07185997· 3. fázis· ArriVent BioPharma, Inc.· Forrás
Contact: Clinical Trials
Még nem toboroz
Ejaculatory Behavior and Seminal Vesicle Size During Radical Prostatectomy
NCT07243795· National Taiwan University Hospital· Forrás
Contact: Yen Ho, M.D.
Toboroz
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
NCT06899126· 3. fázis· Daiichi Sankyo· Forrás
Fut, nem toboroz
Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies
NCT05613621· National Health Research Institutes, Taiwan· Forrás
Toboroz
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
NCT06892548· 1/2. fázis· BioNTech SE· Forrás
Toboroz
Nurse-Led Caregiver Support for Older Adults With Advanced Lung Cancer
NCT07708870· National Taiwan University Hospital· Forrás
Contact: Yeur-Hur Lai, PhD
Toboroz
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
NCT06801834· 3. fázis· Gilead Sciences· Forrás
Toboroz
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
NCT06706076· 1/2. fázis· BlossomHill Therapeutics· Forrás
Fut, nem toboroz
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
NCT06635824· 3. fázis· Genmab· Forrás
Toboroz
Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients
NCT06633003· ALPS Biotech CO. LTD· Forrás
Contact: Irene Tsai
Toboroz
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575· 3. fázis· Jazz Pharmaceuticals· Forrás
Contact: Clinical Trial Disclosure & Transparency
Fut, nem toboroz
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
NCT06157892· 2. fázis· Seagen, a wholly owned subsidiary of Pfizer· Forrás
Fut, nem toboroz
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
NCT06151574· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717· 3. fázis· Theravance Biopharma· Forrás
Fut, nem toboroz
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
NCT05377034· 2. fázis· National Cancer Centre, Singapore· Forrás
Fut, nem toboroz
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
NCT05541380· National Health Research Institutes, Taiwan· Forrás
Fut, nem toboroz
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
NCT05388669· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT05442060· 2. fázis· OBI Pharma, Inc· Forrás
Contact: Anna Hu
Toboroz
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
NCT05429632· 3. fázis· Priothera SAS· Forrás
Contact: Ko Bor-Sheng, MD
Toboroz
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
NCT04864054· 1/2. fázis· Eureka Therapeutics Inc.· Forrás
Contact: Guanlieng Chen
Toboroz
Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
NCT05557474· Chung Shan Medical University· Forrás
Contact: Jin-Shing Chen, MD PhD
Toboroz
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
NCT05215548· 2. fázis· National Taiwan University Hospital· Forrás
Contact: Jin-Shing Chen, M.D., Ph.D
Toboroz
Care Needs in Lung Cancer Patients Receiving Immunotherapy
NCT06433206· National Taiwan University Hospital· Forrás
Contact: Meng Ping Hsiao, Master